Persist AI Raises $12 Million in Series A Funding and Launches Cloud Lab
Persist AI secures $12 million in funding and launches Cloud Lab, enhancing drug formulation efficiency with AI and robotics. 🤖💊
May 22, 2025
Follow us
latest articles
Discover the newest research about AI innovations in 💼 Health Entrepreneurship.
Shropshire Trusts Implement Access Intelligent Care Platform
Shropshire Trusts launch Access Intelligent Care Platform for improved patient data access and care coordination. 📊💙
May 21, 2025
Powys Teaching Health Board Partners with Better for ePMA Implementation
Powys Teaching Health Board partners with Better for ePMA implementation, enhancing patient safety and streamlining prescribing processes. 🏥💊
May 20, 2025
Current diagnosing strategies for Mycobacterium tuberculosis and its drug resistance: a review.
Exploring TB diagnostics: sensitivity, specificity, and AI integration for better outcomes. 🦠🔬📈
May 20, 2025
NHS Suppliers Encouraged to Adopt Cyber Security Best Practices
NHS suppliers urged to adopt cyber security best practices for enhanced protection. Collaboration is key to safeguarding healthcare. 🔒🩺
May 17, 2025
Sprinter Health Raises $55 Million to Enhance Home Healthcare Services
Sprinter Health secures $55 million to enhance in-home healthcare services, providing convenient patient care through technology. 🏥💰
May 17, 2025
Datavant Acquires Aetion to Enhance Real-World Evidence Capabilities
Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. 📊🤝
May 16, 2025
Innovative Use of VR and AI in Nursing at Duke University Health System
Duke University Health System integrates VR and AI in nursing to enhance safety training and improve staff retention. 🏥🤖
May 15, 2025
Collaboration Between NHS, Councils, and Housing Aims to Reduce Hospital Demand
NHS, councils, and housing collaborate to reduce hospital demand using AI insights. This partnership aims to improve patient care. 🏥🤝
May 14, 2025
PhaseV Secures $50 Million in Funding for AI-Driven Clinical Trial Solutions
PhaseV secures $50 million for AI-driven clinical trial solutions, enhancing efficiency in biopharma and CRO operations. 💰🤖
May 13, 2025